Please use this identifier to cite or link to this item: http://hdl.handle.net/10397/99008
PIRA download icon_1.1View/Download Full Text
DC FieldValueLanguage
dc.contributorDepartment of Biomedical Engineering-
dc.contributorMainland Development Office-
dc.contributorDepartment of Applied Biology and Chemical Technology-
dc.contributorPhotonics Research Institute-
dc.creatorZhou, Yen_US
dc.creatorHuang, Xen_US
dc.creatorLi, Jen_US
dc.creatorZhu, Ten_US
dc.creatorPang, Wen_US
dc.creatorChow, Len_US
dc.creatorNie, Len_US
dc.creatorSun, Len_US
dc.creatorLai, Pen_US
dc.date.accessioned2023-06-08T01:09:09Z-
dc.date.available2023-06-08T01:09:09Z-
dc.identifier.urihttp://hdl.handle.net/10397/99008-
dc.language.isoenen_US
dc.publisherMolecular Diversity Preservation International (MDPI)en_US
dc.rights© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https:// creativecommons.org/licenses/by/ 4.0/).en_US
dc.rightsThe following publication Zhou, Y.; Huang, X.; Li, J.; Zhu, T.; Pang, W.; Chow, L.; Nie, L.; Sun, L.; Lai, P. Small Animal In Situ Drug Delivery Effects via Transdermal Microneedles Array versus Intravenous Injection: A Pilot Observation Based on Photoacoustic Tomography. Pharmaceutics 2022, 14, 2689 is available at https://doi.org/10.3390/pharmaceutics14122689.en_US
dc.subjectInjectionen_US
dc.subjectMicroneedles arrayen_US
dc.subjectPhotoacoustic computed tomographyen_US
dc.subjectTransdermal drug deliveryen_US
dc.titleSmall animal in situ drug delivery effects via transdermal microneedles array versus intravenous injection : a pilot observation based on photoacoustic tomographyen_US
dc.typeJournal/Magazine Articleen_US
dc.identifier.volume14en_US
dc.identifier.issue12en_US
dc.identifier.doi10.3390/pharmaceutics14122689en_US
dcterms.abstractIntravenous injection is a rapid, low-cost, and direct method that is commonly used to deliver multifarious biotherapeutics and vaccines. However, intravenous injection often causes trauma or tissue injury that requires professional operation. Transdermal drug delivery overcomes the aforementioned defects, and the microneedles (MNs) array is one of the most promising transdermal drug delivery platforms. Timely, precise, and non-invasive monitoring and evaluation of the effects of MNs in transdermal administration is significant to the research of drug efficiency response to specific diseases. In this sense, photoacoustic computed tomography (PACT), which provides wavelength-selective and deep-penetrating optical contrast, could be a promising imaging tool for in situ evaluation of the treatment effects. In this work, we propose the use of PACT to non-invasively assess the effects of real-time drug delivery in glioma tumors through transdermal administration with degradable indocyanine green-loaded hyaluronic acid MNs (ICG-HA-MNs). The outcome is systematically and quantitatively compared with that via intravenous injection. It is found that the photoacoustic signals of ICG in the tumor site express a faster elevation and shorter duration time in the intravenous injection group; by contrast, the photoacoustic signals demonstrate a lower intensity but prolonged duration time in the MNs group. The observed phenomenon indicates faster response but shorter drug duration for intravenous injection, which is in contrast with the lower loading but prolonged performance for transdermal drug delivery with MNs. These results exhibit good consistency with the earlier, common-sense findings reported from other aspects, confirming that PACT can serve as a potential imaging tool to precisely, non-invasively, and quickly evaluate in situ drug delivery effects and provide constructive guidance for the design and fabrication of microneedles.-
dcterms.accessRightsopen accessen_US
dcterms.bibliographicCitationPharmaceutics, Dec. 2022, v. 14, no. 12, 2689en_US
dcterms.isPartOfPharmaceuticsen_US
dcterms.issued2022-12-
dc.identifier.scopus2-s2.0-85144865771-
dc.identifier.eissn1999-4923en_US
dc.identifier.artn2689en_US
dc.description.validate202306 bcww-
dc.description.oaVersion of Recorden_US
dc.identifier.FolderNumbera2086, a2180b-
dc.identifier.SubFormID46512, 46908-
dc.description.fundingSourceRGCen_US
dc.description.fundingSourceOthersen_US
dc.description.fundingTextNational Natural Science Foundation of China; Hong Kong Innovation and Technology Commission ; Guangdong Science and Technology Commissionen_US
dc.description.pubStatusPublisheden_US
dc.description.oaCategoryCCen_US
Appears in Collections:Journal/Magazine Article
Files in This Item:
File Description SizeFormat 
pharmaceutics-14-02689-v2.pdf13.02 MBAdobe PDFView/Open
Open Access Information
Status open access
File Version Version of Record
Access
View full-text via PolyU eLinks SFX Query
Show simple item record

Page views

105
Last Week
0
Last month
Citations as of Nov 10, 2025

Downloads

74
Citations as of Nov 10, 2025

SCOPUSTM   
Citations

10
Citations as of Dec 19, 2025

WEB OF SCIENCETM
Citations

9
Citations as of Dec 18, 2025

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.